Allay Therapeutics raises $45M for ongoing Series D; Encoded’s layoffsnews2025-02-13T15:41:11+00:00February 13th, 2025|Endpoints News|
Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tabletnews2025-02-12T15:33:21+00:00February 12th, 2025|Endpoints News|
IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonicnews2025-02-11T15:21:39+00:00February 11th, 2025|Endpoints News|
Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar dealnews2025-02-10T15:21:51+00:00February 10th, 2025|Endpoints News|
AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’snews2025-02-06T15:43:32+00:00February 6th, 2025|Endpoints News|
Bristol Myers, Kyowa Kirin disclose layoffsnews2025-02-05T16:26:26+00:00February 5th, 2025|Endpoints News|
Turnstone stops TIL studies; GH Research’s $150M offeringnews2025-02-04T15:39:12+00:00February 4th, 2025|Endpoints News|
Tectonic to raise $185M; Acelyrin drops rights to Affibody drugnews2025-02-03T15:04:37+00:00February 3rd, 2025|Endpoints News|
Ironwood’s layoffs; Shionogi’s RSV pill succeeds in Phase 2news2025-01-30T15:50:07+00:00January 30th, 2025|Endpoints News|
Curie.Bio has a new $340M fund; Layoffs at Benchling, I-Mabnews2025-01-29T15:10:17+00:00January 29th, 2025|Endpoints News|
